Key points are not available for this paper at this time.
This paper addresses some of the issues relatedto health care in the United States. In so doing, I give primaryemphasis to questions involving access to health care. Even so, I limit the discussion of any particular topic to its most important facets. The principle of selection involves various criteria: insofar as possible, I discuss those issues that are important at a system level (particularly as they impinge on the allocation of resources), that involve economic arrangements influencing behavior and performance, and that can be illuminated by the economist’s perspective. I attempt to give primary emphasis to those variables whose influence is far ranging. In so doing, of course, we cannot examine every network of inter-relations. Although this simplifies the discussion, we pay a price for incompleteness. There is little choice, however. One of the difficulties with the health field stems from the fact that everything is interrelated: that intervention on one front has “side effects ” on other fronts; that intervention designed to accomplish one purpose sometimes fails to do so because other factors that appear unrelated are not changed. To discuss everything is impossible. On the other hand, to say nothing because we cannot discuss everything is irresponsible. Finally, we will have to reach judgments even in spite of the rela-tive weakness of the data available for analysis. We know far less, for example, about the availability of services (particularly if corrected for quality differentials) than we would like to. So, too, with the impact of differences in utilization on levels of health. The current refrain often seems to be, “But we have no output measures. ” That, regrettably, is frequently the case. Nevertheless, just as we cannot be silent because of
Rashi Fein (Fri,) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: